alo
vera
alo
barbadensi
miller
wide
use
speci
commerci
therapeut
properti
cardarelli
et
al
kojo
qian
chen
et
al
plant
contain
two
materi
juici
consist
first
yellow
exud
contain
high
concentr
anthraquinonetyp
compound
use
decad
cathart
purg
second
clear
mucilagin
gel
use
sinc
ancient
time
treatment
burn
wound
fox
et
al
reynold
dweck
among
chemic
compon
exud
aloin
emodin
aloeemodin
barbaloin
isobarbaloin
chrysophan
acid
compound
shown
possess
antibacteri
fungicid
diuret
lax
antivir
hepatoprotect
vasorelax
activ
salah
et
al
drudi
et
al
gel
highli
rich
polysaccharid
respons
immunostimul
antiinflammatori
properti
gel
differ
type
molecul
isol
speci
differ
activ
compound
identifi
hamman
reynold
southeast
mexico
product
alo
leav
cover
area
approxim
ha
siap
local
commerci
alo
product
base
concentr
gel
leav
cosmet
industri
produc
also
commerci
aloin
obtain
leav
exud
pharmaceut
industri
process
high
content
solid
agricultur
residu
gener
root
use
local
raw
materi
rais
pharmaceut
interest
quinon
content
despit
mani
pharmacolog
activ
avail
materi
aloeemodin
emodin
chrysophan
acid
test
influenza
viru
iav
li
et
al
iav
segment
negativesens
envelop
singlestrand
rna
viru
belong
famili
orthomyxovirida
taubenberg
bouvier
pales
infect
viru
caus
respiratori
diseas
human
anim
high
morbid
mortal
rate
iglesia
et
al
naesen
et
al
vaccin
prevent
influenza
viru
infect
antivir
drug
use
treat
infect
patient
howev
hamper
high
variabl
iav
surfac
glycoprotein
na
ha
mainli
emerg
resist
strain
burnham
et
al
li
et
al
mckimmbreschkin
consid
broad
pharmacolog
activ
vera
quinon
aim
studi
investig
antivir
activ
aloesaponarini
aloesaponarinii
deriv
influenza
viru
studi
also
contribut
knowledg
potenti
pharmaceut
use
vera
crop
industri
residu
analyt
tlc
carri
use
aluminiumsilica
gel
plate
em
merck
mm
thick
chromatograph
purif
perform
use
silica
gel
mm
merck
detect
compon
uvvi
light
nm
perform
use
uv
cabinet
variou
compon
chromatogram
visual
use
solut
phosphomolybd
acid
g
ceric
sulfat
g
ml
sulfur
acid
follow
heat
specif
reagent
quinon
detect
use
reagent
gel
permeat
column
chromatographi
carri
use
sephadex
pharmacia
chemic
solvent
reagent
quinon
derivat
sodium
hydroxid
dimethyl
sulfat
potassium
carbon
anhydr
dichloromethan
tetrabutyl
ammonium
bromid
tetraoacetyl
glucos
bromid
commerci
obtain
fluka
fermont
sigmaaldrich
analyt
pure
root
vera
collect
may
plantat
belong
mr
abelino
pool
municip
maxcanu
yucatan
mexico
root
airdri
ground
brabend
dusiburg
mill
use
siev
powder
root
kg
extract
three
time
cold
meoh
room
temperatur
h
l
meoh
g
dri
materi
fig
extract
combin
solvent
remov
pressur
produc
g
crude
methanol
extract
g
extract
suspend
mixtur
watermeoh
ca
ml
solut
g
crude
methanol
extract
result
suspens
partit
etoac
yield
medium
polar
extract
g
success
flash
chromatographi
use
gradient
elut
mixtur
nhexan
acoetmeoh
nhexaneaceton
g
acoet
extract
result
isol
metabolit
mg
mg
pure
form
purif
acoet
extract
obtain
addit
amount
compound
mg
mg
gener
experiment
procedur
derivat
metabolit
metabolit
obtain
good
yield
subject
chemic
modif
methyl
acetyl
oglycosyl
reaction
addit
deriv
pentaacetyl
glucos
also
prepar
briefli
methyl
reaction
mixtur
mg
mmol
ch
ml
k
co
mg
ml
aceton
left
stir
room
temperatur
h
dilut
ml
water
result
solut
extract
ethyl
acet
ml
evapor
solvent
mg
yield
compound
obtain
orang
needl
acetyl
reaction
mixtur
mg
mmol
acet
anhydrid
ml
pyridin
ml
allow
stir
overnight
room
temperatur
reaction
mixtur
pour
water
ml
result
suspens
extract
ethyl
acet
time
organ
layer
wash
v
v
success
water
hcl
nahco
nacl
satur
solut
treatment
solvent
anhydr
na
follow
filtrat
evapor
yield
mg
yield
pure
compound
final
prepar
oglucosyacetyl
oglucosyl
deriv
employ
phasetransf
reaction
follow
gener
procedur
report
halazi
et
al
briefli
hermet
seal
contain
contain
tetrabutylammonium
bromid
solut
natur
compound
anhydr
ch
cl
ad
stir
minut
v
v
naoh
solut
ad
mixtur
allow
stir
min
colour
chang
occur
distil
water
ad
subsequ
solut
anhydr
ch
cl
ad
volum
adjust
distil
water
ratio
organ
phase
aqueou
phase
mixtur
remain
stir
room
temperatur
h
time
period
mixtur
adjust
ph
v
v
hcl
solut
ml
distil
water
ad
extract
ch
cl
ml
dri
anhydr
na
filter
solvent
evapor
obtain
oglucosyacetyl
deriv
mg
mmol
compound
mg
oglucosyacetyl
compound
yield
obtain
addit
mg
mmol
compound
gave
mg
compound
obtain
oglucosyl
deriv
mg
mmol
compound
dissolv
ml
ethanol
ml
hcl
ad
mixtur
stir
warm
h
reflux
cool
solut
dri
rotari
evapor
residu
purifi
flash
column
chromatographi
employ
etoac
yield
mg
yield
deriv
yellow
powder
nmr
employ
chemic
character
compound
chemic
character
h
nmr
mhz
c
nmr
mhz
spectra
obtain
bruker
avanc
spectromet
use
residu
chcl
signal
ppm
h
c
respect
meoh
residu
signal
h
c
refer
ga
chromatographi
mass
spectrometri
cgem
analys
run
agil
technolog
chromatograph
model
n
coupl
mass
spectromet
model
use
follow
chromatograph
condit
split
inject
concentr
sampl
ultra
column
layer
thick
flow
rate
mlmin
helium
carrier
ga
oven
temperatur
programm
sd
min
ta
min
gradient
injector
detector
temperatur
fid
lchrm
data
acquir
bruker
mxisqtof
mass
spectromet
bruker
dalton
gmbh
bremen
germani
coupl
lc
system
mass
spectra
collect
mz
mz
posit
mode
canin
kidney
cell
influenza
virus
suscept
oseltamivir
resist
oseltamivir
provid
virolog
laboratori
region
research
centr
universidad
autonoma
de
mdck
cell
grown
plate
cell
densiti
cell
per
well
incub
co
h
cell
wash
twice
pb
ph
gibco
soon
cell
incub
compound
dilut
rang
dmem
h
co
incub
cell
fix
stain
crystal
violet
methanol
absorb
measur
wavelength
nm
multilabel
plate
reader
victor
x
perkinelm
assay
perform
triplic
cell
viabil
determin
ratio
optic
densiti
od
treat
cell
od
cell
control
consid
viabl
cell
cell
viabil
od
treat
cell
od
cell
control
cytotox
concentr
calcul
regress
analysi
antivir
assay
cytopath
effect
cpe
reduct
assay
mdck
cell
seed
cell
densiti
cell
well
incub
h
co
measur
cpe
reduct
effect
cell
infect
influenza
viru
moi
presenc
variou
concentr
compound
modifi
eagl
media
dmem
gibco
supplement
tpck
trypsin
ml
incub
co
h
time
cpe
reduct
observ
light
microscop
cell
stain
crystal
violet
methanol
od
measur
wavelength
nm
cpe
reduct
calcul
use
formula
od
cell
infect
treat
compound
b
od
viru
control
c
od
cell
control
mean
inhibitori
concentr
ic
defin
concentr
inhibit
cep
reduct
infect
cell
calcul
nonlinear
regress
analysi
use
graphpad
prism
programm
version
mdck
cell
seed
cell
densiti
cell
well
plate
h
co
cell
monolay
incub
serial
dilut
supernat
concentr
compound
cpe
assay
h
time
inoculum
remov
agaros
ad
overlay
medium
incub
h
co
soon
agar
remov
stain
crystal
violet
methanol
number
plate
count
activ
compound
compar
viral
control
oseltamivir
control
assess
effect
deriv
viral
cycl
h
timeofaddit
experi
perform
previous
describ
zhang
et
al
yamada
et
al
furuta
et
al
fig
briefli
cell
seed
plate
incub
influenza
viru
strain
moi
one
hour
viral
absorpt
monolay
incub
dmem
ml
trypsintpck
co
time
zero
medium
contain
compound
ad
time
h
incub
inoculum
remov
fresh
medium
ad
incub
h
postinfect
supernat
collect
viral
product
determin
plaqu
assay
result
repres
averag
three
independ
experi
standard
deviat
oneand
twoway
anova
analysi
perform
determin
signific
differ
respect
control
acoet
extract
root
vera
metabolit
obtain
pure
form
yield
respect
metabolit
show
follow
physic
characterist
aloesaponarin
yagi
et
aloesaponarin
ii
yagi
et
deriv
character
use
h
nmr
lchrm
togeth
gcm
compound
readili
deduc
comparison
spectroscop
data
h
nmr
c
nmr
spectroscop
data
found
literatur
lee
et
al
yagui
et
al
except
deriv
new
structur
compound
obtain
intermedi
compound
oglucosyl
reaction
h
nmr
c
nmr
data
along
molecular
formula
compound
indic
tetracycl
skeleton
contain
two
aromat
ring
correspond
anthraquinonetyp
compound
h
nmr
spectrum
also
show
expect
four
sugar
acetyl
signal
lchrm
spectra
show
singl
peak
retent
time
min
molecular
ion
peak
mz
valu
calcd
c
h
nmr
spectra
allow
complet
character
deriv
use
previous
mention
data
compound
elucid
aloesaponarin
new
deriv
compound
isol
yellow
needl
show
similar
h
nmr
c
nmr
data
except
addit
aromat
proton
j
hz
aloesaponarin
ii
anthraquinon
structur
consequ
compound
determin
new
aloesaponarin
ii
deriv
obtain
yellow
powder
lchrm
spectra
show
singl
peak
retent
time
min
molecular
ion
peak
mz
valu
calcd
c
h
ir
spectrum
absorpt
band
cm
hydroxyl
group
cm
conjug
carbonyl
group
cm
aromat
ring
cm
ester
group
hnmr
c
nmr
cd
od
spectra
indic
presenc
anthraquinon
structur
dd
j
hz
j
hz
dd
j
hz
anomer
proton
j
hz
addit
acetyl
group
acetyl
one
methyl
proton
furthermor
heteronuclear
multipl
bond
connect
hmbc
experi
longrang
correl
observ
proton
carbon
confirm
sugar
moieti
aglycon
basi
evid
confirm
deriv
new
aloesaponarin
deriv
deriv
show
follow
physic
characterist
h
nmr
spectrum
cdcl
mhz
deriv
shown
fig
aloesaponarin
spectroscop
data
new
deriv
avail
onlin
supplementari
materi
cytotox
cytopath
reduct
cpe
effect
natur
anthraquinon
deriv
fig
togeth
pentaacetyl
sugar
evalu
none
quinon
pentaacetyl
sugar
show
signific
cytotox
effect
cc
mdck
cell
indic
cell
viabil
concentr
test
assess
cpe
reduct
observ
tabl
compound
show
weak
cpe
reduct
ic
suscept
strain
ic
valu
similar
present
compound
resist
strain
contrast
compound
next
assess
result
cpe
use
compound
correl
reduct
viral
yield
posttreat
experi
done
use
plaqu
inhibit
assay
determin
viral
titr
serial
dilut
concentr
compound
evalu
triplic
use
strain
experi
infecti
particl
titrat
viral
sampl
obtain
directli
posttreat
shown
fig
behaviour
compound
dosedepend
significantli
reduc
viral
titr
concentr
howev
antivir
activ
drastic
decreas
lowest
concentr
evalu
hand
compound
also
dosedepend
behaviour
antivir
activ
maintain
rang
found
less
activ
compound
effect
compound
singlecycl
replic
h
influenza
viru
perform
use
compound
life
cycl
influenza
viru
last
h
divid
three
stage
viral
entri
h
b
replic
translat
viral
genom
h
c
releas
viral
progeni
h
stage
pharmacolog
target
inhibitori
molecul
way
compound
ad
differ
time
viral
infect
base
ic
valu
ic
compound
evalu
use
viru
seen
fig
compound
decreas
viral
product
ad
h
postinfect
manner
compound
reduc
viral
product
viru
period
time
h
result
suggest
compound
inhibit
viral
product
viru
infect
work
describ
isol
derivat
antivir
evalu
main
anthraquinon
obtain
root
vera
h
nmr
c
nmr
experi
lchrm
compound
allow
complet
character
new
anthraquinon
deriv
deriv
obtain
good
yield
antivir
evalu
sever
vitro
assay
perform
base
indirect
cpe
reduct
assay
direct
plaqu
inhibit
test
timeofaddit
experi
method
former
abil
compound
inhibit
viru
replic
mdck
cell
measur
latter
abil
compound
reduc
viral
titer
determin
sidwel
smee
chattopadhyay
et
al
plaqu
reduct
assay
timeofaddit
result
suggest
antivir
activ
compound
increas
posttreat
level
structureact
relationship
influenza
viru
isol
togeth
deriv
assess
result
found
acetyl
methyl
oglycosyl
addit
improv
antivir
activ
compound
howev
acetyl
sugar
ad
moder
antivir
effect
observ
besid
acetyl
glucos
unabl
caus
cpe
reduct
influenza
virus
base
analysi
structureact
relationship
infer
tetraacetyl
glucos
residu
posit
compound
import
role
antivir
activ
tetraaceyl
glucos
antiinfluenza
effect
therefor
bind
oglucosyl
anthraquinon
relev
antivir
activ
lipophil
also
play
import
role
sinc
polar
deriv
glucos
posit
activ
contrast
otetraacetylglucosyl
compound
probabl
explan
antivir
activ
may
due
structur
similar
tetraacetyl
glucos
residu
sialic
acid
receptor
oxygen
cyclohexan
structur
core
increas
interact
either
viru
hemagglutinin
ha
andor
viral
sialidas
neuraminidas
nishikawa
et
al
contrari
none
aglycon
show
antivir
activ
except
aglycon
lack
acetyl
group
posit
accord
literatur
studi
describ
antivir
structureact
relationship
quinon
report
silico
studi
juglon
made
yang
et
al
point
quinon
abl
interact
ha
na
glycoprotein
influenza
viru
interact
mainli
ring
format
strong
hydrogen
bridg
activ
site
anoth
studi
bodian
et
al
mention
quinon
fusion
inhibitori
molecul
influenza
viru
share
structur
similar
presenc
hidrofob
ring
posit
hidrofob
sustitu
compound
antivir
activ
natur
quinon
deriv
isol
plant
demonstr
parainfluenza
viru
andersen
et
al
sarscov
park
et
al
influenza
viru
li
et
al
sydiski
et
al
feng
et
al
wang
et
al
howev
inform
influenc
addit
otetraacetylglucosyl
group
alo
anthraquinon
effect
inhibit
influenza
viru
present
result
encourag
studi
anthraquinon
deriv
especi
otetraacetylglucosyl
group
vitro
vivo
experi
due
high
abund
tabl
cytotox
antivir
activ
compound
materi
vera
crop
agroindustri
residu
studi
report
first
time
character
chemic
modif
main
anthraquinon
vera
root
attempt
demonstr
new
potenti
use
anthraquinon
deriv
result
suggest
possibl
antivir
activ
influenza
viru
two
new
deriv
aloesaponarin
aloesaponarin
ii
result
add
valu
vera
crop
could
consid
promis
sourc
either
raw
materi
new
deriv
potenti
pharmaceut
interest
author
declar
conflict
interest
